Get the Stockscreener App
1.06
0.95%
0.01
Pre-market:
1.04
-0.02
-1.89%
Vivani Medical Inc stock is traded at $1.06, with a volume of 64,975.
It is up +0.95% in the last 24 hours and down -3.64% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
See More
Previous Close:
$1.05
Open:
$1.05
24h Volume:
64,975
Relative Volume:
0.71
Market Cap:
$61.61M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-2.1633
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
+4.95%
1M Performance:
-3.64%
6M Performance:
-15.87%
1Y Performance:
-42.39%
1-Day Range:
$1.04
$1.08
1-Week Range:
$1.01
$1.08
52-Week Range:
$0.9054
$2.09
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818-833-5000
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.06 | 61.61M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
HC Wainwright Reaffirms "Buy" Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - GlobeNewswire
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - Benzinga
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 44,400 Shares of Stock - MarketBeat
Vivani medical director Gregg Williams buys $21,233 in stock - Investing.com Australia
Vivani medical director Gregg Williams buys $21,233 in stock By Investing.com - Investing.com South Africa
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com South Africa
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 34,000 Shares of Stock - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical's director Gregg Williams acquires $205k in stock - Investing.com Australia
Vivani Medical’s director Gregg Williams acquires $205k in stock - Investing.com
Vivani Medical’s director Gregg Williams acquires $205k in stock By Investing.com - Investing.com South Africa
Vivani Medical's director Gregg Williams acquires $205k in stock By Investing.com - Investing.com India
Vivani Medical Director Gregg Williams Acquires Over 200K Shares - TradingView
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant - MarketScreener
Vivani Medical (NASDAQ:VANI) Earns Buy Rating from HC Wainwright - Defense World
Vivani medical director Gregg Williams buys $24,959 in stock - Investing.com Australia
Vivani medical director Gregg Williams buys $24,959 in stock By Investing.com - Investing.com UK
Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m - simplywall.st
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target By Investing.com - Investing.com Canada
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target - Investing.com
Vivani medical chief business officer purchases $4,100 in shares By Investing.com - Investing.com South Africa
Vivani medical chief business officer purchases $4,100 in shares - Investing.com India
Vivani Medical’s Strategic Positioning and Promising Developments Earn a Buy Rating Despite Price Target Reduction - TipRanks
Vivani Medical (NASDAQ:VANI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Vivani Medical: Q4 Earnings Snapshot - CT Insider
Vivani Medical Reports 2024 Financial Results and Business Progress - TipRanks
Vivani Medical Inc. (VANI) reports earnings - Quartz
Vivani Medical Advances with Successful Milestones in 2024 - TipRanks
Vivani Medical, Inc. SEC 10-K Report - TradingView
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
HC Wainwright Reaffirms Buy Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical announces $8.25M private placement equity financing - MSN
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment - Asianet Newsable
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):